Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

NCT06354465 is registered in ClinicalTrials.gov with Lifespan as lead sponsor.

NCT NCT06354465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06354465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews
Lead sponsor
Lifespan
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
July 1, 2024
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

criminal justice, opioid use disorder, treatment adherence and compliance